Sunday, November 30, 2014

Hot Value Companies To Own In Right Now

Activist investor Carl Icahn placed a $350 million bet on Netflix (NASDAQ: NFLX  ) last fall, with intentions of changing the company. Selling Netflix to the highest bidder was one option in Icahn's mind, and perhaps his strongest idea.

But now, his investment has nearly quadrupled in value, adding a cool $1 billion to the original stake. And that's not enough: Icahn, who still hasn't sold a single Netflix share, no longer wants to change or sell the company, and is generally very happy, according to The Wall Street Journal . "When I saw House of Cards, and met with [CEO Reed Hastings], I was sold on what he was doing," Icahn told the Journal.

In this video, Fool contributor Anders Bylund puts Icahn's happiness into perspective. Icahn has bet on the wrong horse in the video sweepstakes before, but he's on the right track this time.

Hot Dow Dividend Companies To Own For 2015: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Jim Jubak]

    But it just doesn't seem to matter for Schlumberger (SLB). Schlumberger is a member of my Jubak's Picks portfolio.

    On January 17, the oil services and technology company reported fourth quarter earnings of $1.35 a share, beating Wall Street estimates by two cents a share. Earnings grew by 29.8% year over year.

  • [By Holly LaFon]

    Schlumberger (SLB) was a top performer during the quarter, continuing its strong performance since the summer of 2012. Since late June 2012 (6/22) through mid-颅��April 2014, the stock (a holding since late September 2011) is up approximately 60% -颅��nearly double the S&P 500 Index's gain of 36%. Schlumberger continues to do what it does best ��dominate their respective industry and generate industry-颅��leading growth and cash flow generation. The Company is a leading global provider of oil services. At the risk of repeating an oil service industry clich茅, "the easy oil has been found." The technological development being brought to bear to the extremes and complexities in the exploration and development of hydrocarbon energy is relentless. The Company's depth and breadth of their integrated products and services has been at the forefront of the unceasing progress of energy services for decades. Indeed, according to the Company, over the past decade, total E&P capital expenditures have increased by 400%, yet global oil production is up only a scant 15%. Furthermore, in just the last three years, the upstream E&P industry has spent on average $600 billion per year yielding only a net increase in global oil production coming from the shale deposits in North American. Due to the significant advancements in horizontal drilling and multistage fracking natural gas prices are generally one-颅��hird of what they are in Europe or Asia. This differential has had 2 profound implications, for instance in the U.S. chemical industry. Chevron Phillips just this month broke ground on a $6 billion ethane cracker plant in Texas ��the first petrochemical refinery built in the U.S. in twenty-颅��ive years. Circa-颅��014 finds the Company at the cutting edge in the continued search for unconventional oil and gas, plus in the environmentally challenging area in offshore and deepwater. The Company continues to enhance their capabilities, scale and integra

  • [By David Smith]

    Another angle
    Without taking hindsight issue with that statement, I'm forced to compare it to the assessment of the same subject on the same day by Schlumberger's (NYSE: SLB  ) CEO Paal Kibsgaard, who observed during his company's call that "... the main concern in North America land remains the pricing, where the downwards trend in drilling, wireline, and coiled tubing seen in the fourth quarter continued in Q1. In addition, we also saw further downward pricing pressure on a number of hydraulic fracturing bids during the quarter, adding further uncertainty to the North America land market outlook."�

Hot Value Companies To Own In Right Now: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:
  • [By Daniel Miller]

    The U.S. economy has rebounded gradually, which is more than the rest of the world can say. Unfortunately for Caterpillar (NYSE: CAT  ) , which derives the majority of its profits internationally, a global rebound can't come soon enough. The stock is down about 22% over the last 12 months and sits at a price to earnings ratio well below its historical average. Caterpillar recently released its first-quarter information, which disappointed investors but its stock price remained unaffected ��it even rose in the days after the earnings release. Does this mean Caterpillar stock has finally bottomed out, giving investors a chance to buy in?

Hot Value Companies To Own In Right Now: Tupperware Corporation(TUP)

Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.

Advisors' Opinion:
  • [By Jonathan Berr]

    Multilevel marketing (MLM) groups such as Herbalife operate through independent sales representatives, who earn money both through the sales of product and by recruiting other people to join their team. This business model — which is used by scores of companies, including�Pampered Chef, which is owned by Warren Buffett’s Berkshire Hathaway (BRK.B), Tupperware (TUP) and Mary Kay Cosmetics — is legal provided that actual products are sold.

  • [By Eric Volkman]

    Tupperware Brands (NYSE: TUP  ) is reaching into its corporate bowl for a fresh payout to shareholders. The company has declared a quarterly dividend of $0.62 per share. This will be paid on July 8 to stockholders of record as of June 19. That amount matches the firm's previous distribution, which was paid in early April. Prior to that, Tupperware Brands was rather less generous, handing out $0.36 per share.

  • [By James Brumley]

    CSCO stock might be one of the market’s dark-horse stories of 2014; the dividend yield is the icing on the cake.

    Dividend Stocks to Buy: Tupperware Brands (TUP)

    Dividend Yield: 3.2%

  • [By John Kell]

    Among the companies with shares expected to actively trade in Wednesday’s session are Dow Chemical Co.(DOW), Tupperware Brands Corp.(TUP) and Yahoo Inc.(YHOO)

Hot Value Companies To Own In Right Now: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Deutsche Bank is making a change in its coverage of dollar store themes on Monday: Dollar Tree Inc. (NASDAQ: DLTR) was raised to Buy from Hold and Family Dollar Stores Inc. (NYSE: FDO)�was downgraded to Hold from Buy, but the price target was raised to $74 from $70.

  • [By WWW.DAILYFINANCE.COM]

    Consumers and cooks have an expectation that mayonnaise should both taste and perform like mayonnaise.

    "Consumers and cooks have an expectation that mayonnaise should both taste and perform like mayonnaise. Just Mayo does neither," the complaint states, noting that the Hampton Creek product's oils separate when heated. Unilever holds the biggest share of the U.S. mayonnaise market, which is estimated to be worth $2 billion annually, according to market-research firm Euromonitor. That's more than twice the size of the ketchup market. Hampton Creek didn't return calls from The Associated Press seeking comment Tuesday morning. The company told The Wall Street Journal that it doesn't mislead consumers because it advertises the absence of eggs as a benefit. But a marketing professor hired by Unilever to survey consumers found in an online survey that more than half of thought Just Mayo was mayonnaise when they saw the label. The professor said in a document filed last week that 822 consumers participated in the research. Just Mayo is the first product from Hampton Creek, a San Francisco-based startup that touts the backing of Microsoft (MSFT) founder Bill Gates and Li Ka-shing, Asia's wealthiest person. Just Mayo is available at Dollar Tree (DLTR), Whole Foods Market (WFM) and Kroger (KR) stores, among other locations. Hellmann's celebrated its 100th anniversary last year. Mayonnaise originated in France in the 1700s, when a chef seeking to make a creamy sauce combined oil and egg yolks.

  • [By Brendan Byrnes]

    Brendan: Not a problem at all. What about the surprising amount of dollar-store companies that are public? You have Family Dollar (NYSE: FDO  ) , Dollar Tree (NASDAQ: DLTR  ) , Dollar General (NYSE: DG  ) . You mention, in particular, Family Dollar, which is the lowest market cap out of all of those, as doing the best, an exceptional company. Why?

Monday, November 24, 2014

10 Best Solar Stocks To Buy Right Now

10 Best Solar Stocks To Buy Right Now: First Solar Inc.(FSLR)

First Solar, Inc. manufactures and sells solar modules using a thin-film semiconductor technology. It also designs, constructs, and sells photovoltaic solar power systems. The company?s solar modules employ a thin layer of semiconductor material to convert sunlight into electricity. Its integrated solar power systems activities include the project development; engineering, procurement, and construction services; operating and maintenance services; and project finance. The company sells solar modules to project developers, system integrators, and operators of renewable energy projects; and solar power systems to investor owned utilities, independent power developers and producers, and commercial and industrial companies, as well as other system owners. It operates in the United States, Germany, France, Canada, and internationally. The company was formerly known as First Solar Holdings, Inc. and changed its name to First Solar, Inc. in 2006. First Solar was founded in 1999 a nd is headquartered in Tempe, Arizona.

Advisors' Opinion:
  • [By Travis Hoium]

    The utility scale boom
    The current growth in residential solar wouldn't be possible without SunPower and First Solar (NASDAQ: FSLR  ) first proving the efficacy of solar on a large scale. The two companies have built hundreds of megawatts of projects over the past decade and have proved that you can model the output of solar power and turn it into an investable asset. Projects of 25 MW+ are still the biggest driver of installations in the U.S., and they're financed very much like mortgages or a depreciating assets.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/10-best-solar-stocks-to-buy-right-now-2.html

Saturday, November 22, 2014

10 Best Quality Stocks To Invest In 2014

The growth in the financial planning industry over the past few decades has led to the establishment of several professional associations that are dedicated to furthering the interest of advisors as well as protecting and educating the public. Three major organizations now stand above the rest in this category: The Financial Planning Association (FPA), the National Association of Personal Financial Advisors (NAPFA), and the National Association of Insurance and Financial Advisors (NAIFA). These organizations each provide a wealth of benefits for both advisors and consumers that have combined to elevate the quality and public perception of the financial planning industry in the U.S.

The Financial Planning Association (FPA)
The FPA was created at the beginning of 2000 with the merger of the Institute of Certified Financial Planners (ICFP) and the International Association of Financial Planning (IAFP). One of its chief goals is to help the public understand what services financial planners can provide and exactly how they will pay for them. The FPA requires all members to adhere to its standard of care, which includes full disclosure of all forms of compensation and possible conflicts of interest. The FPA website provides a wealth of tools and resources for consumers including articles, book, brochures, a financial planning blog, a retirement planning app for smartphones and a search feature that allows users to find member planners in their area. It also sponsors several community outreach programs that are designed to promote consumer awareness of the importance of financial planning, including:

Top 5 Industrial Disributor Stocks To Buy For 2015: Powershares Dynamic Media Portfolio (PBS)

PowerShares Dynamic Media Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Dynamic Media Intellidex Index (the Media Intellidex). The Media Intellidex consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. These companies may include advertising, marketing and public relations companies; companies that own, operate or broadcast free or pay television, radio or cable stations; theaters; film studios; publishers or sellers of newspapers, magazines, books or video products; printing, cable television and video companies and equipment providers; pay-per-view television companies; companies involved in emerging technologies for the broadcast and media industries; cellular communications companies; companies involved in the development, syndication and transmission of television, movie programming, advertising and cellular communications; companies that distribute data-based information, and other companies involved in the ownership, operation or development of media products or services. Stocks are selected principally on the basis of their capital appreciation potential as identified by the AMEX (the Intellidex Provider) pursuant to its Intellidex methodology.

The Fund will normally invest at least 80% of its total assets in common stocks of media companies. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Media Intellidex. The Media Intellidex is adjusted quarterly, and the Fund, using an indexing investment approach, attempts to replicate the performance of the Media Intellidex. The Fund�� investment advisor is PowerShares Capital Management LLC.

Advisors' Opinion:
  • [By John Udovich]

    On Monday, shares of small cap�Rocket Fuel Inc (NASDAQ: FUEL) took off like a rocket by surging 18.96% after plunging about 20% on Friday after earnings���meaning it might be time to take a closer look at the stock as well as benchmark it with the performance of�the Global X Social Media Index ETF (NASDAQ: SOCL) and the PowerShares Dynamic Media Portfolio ETF (NYSEARCA: PBS).

  • [By John Udovich]

    Small cap media stock�LIN Media LLC (NYSE: LIN) might not be a household name, but there is a good chance you might be watching the company�� programs because like the Sinclair Broadcast Group, Inc (NASDAQ: SBGI) and Nexstar Broadcasting Group, Inc (NASDAQ: NXST), its helping to consolidate the media industry plus its making investment in other forms of media like social media. The stock has also outperformed those two peers along with the�PowerShares Dynamic Media Portfolio ETF (NYSEARCA: PBS).

10 Best Quality Stocks To Invest In 2014: Delcath Systems Inc.(DCTH)

Delcath Systems, Inc., a development stage company, operates as a specialty pharmaceutical and medical device company. It focuses on cancers in the liver. The company involves in the development and clinical study of the Delcath chemosaturation system. Its clinical trial include a Phase III multi-center study for patients with unresectable metastatic ocular or cutaneous melanoma exclusively or predominantly in the liver; and a multi-arm Phase II clinical trial of the Delcath chemosaturation system with melphalan in patients with primary and metastatic liver cancer, which comprise neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York.

Advisors' Opinion:
  • [By Monica Gerson]

    Delcath Systems (NASDAQ: DCTH) is expected to post a Q4 loss at $0.05 per share on revenue of $100.00 thousand.

    Emerald Oil (NYSE: EOX) is projected to post a Q4 loss at $0.02 per share on revenue of $18.04 million.

  • [By John Udovich]

    Biotech in general has been one of the market�� hottest sectors this year thanks to plenty of mostly good news�along with�new IPOs while small cap biotech stocks Delcath Systems (NASDAQ: DCTH), ZIOPHARM Oncology Inc (NASDAQ: ZIOP), Recro Pharma (NASDAQ: REPH), TetraLogic Pharmaceuticals (NASDAQ: TLOG)�and TNI BioTech (OTCMKTS: TNIB) have also produced their share of news�this week or in recent weeks. Just consider the following:

10 Best Quality Stocks To Invest In 2014: Niska Gas Storage Partners LLC (NKA)

Niska Gas Storage Partners LLC owns and operates natural gas storage assets in North America. It owns or contracts for approximately 185.5 billion cubic feet of total gas storage capacity. The company owns and operates gas storage facilities in Alberta, Canada, as well as in northern California and Oklahoma, the United States. Its gas storage customers include financial institutions, producers, marketers, power generators, pipelines, and municipalities. The company was founded in 2006 and is headquartered in Houston, Texas.

Advisors' Opinion:
  • [By Seth Jayson]

    Niska Gas Storage Partners (NYSE: NKA  ) is expected to report Q1 earnings on Aug. 1. Here's what Wall Street wants to see:

    The 10-second takeaway
    Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Niska Gas Storage Partners's revenues will contract -1908.0% and EPS will contract -9.5%.

10 Best Quality Stocks To Invest In 2014: Asbury Automotive Group Inc (ABG)

Asbury Automotive Group, Inc. (Asbury), incorporated on February 15, 2002, is an automotive retailers in the United States. As of December 31, 2011, the Company operated 99 franchises (79 dealership locations). It offers a range of automotive products and services, including new and used vehicles; vehicle maintenance; replacement parts and collision repair services; new and used vehicle financing, and aftermarket products, such as insurance, warranty and service contracts. As of December 31, 2011, it offered 30 domestic and foreign brands of new vehicles. Its brand mix is weighted 84% towards luxury and mid-line import brands, with the remaining 16% consisting of domestic brands. As of December 31, 2011, it operated dealerships in 18 metropolitan markets throughout the United States. As of December 31, 2011, its retail network consisted of eight locally-branded dealership groups. As of December 31, 2011, its brand names included Nalley Automotive Group, Courtesy Autogroup, Coggin Automotive Group, Crown Automotive Company, David McDavid Auto Group, North Point Auto Group, Gray-Daniels Auto Family and Plaza Motor Company. During the year ended December 31, 2011, the Company sold its heavy truck business in Atlanta, Georgia, two franchises and one additional ancillary business. On May 2, 2011, the Company sold its luxury brand dealership in California. In December 2012, the Company acquired a Volkswagen and a Bentley store in the Atlanta, Georgia market.

New Vehicle Sales

As of December 31, 2011, the Company owned a range of 30 American, European and Asian brands. Its new vehicle unit sales consist of the sale of new vehicles to individual retail customers (new vehicle retail) and the sale of new vehicles to commercial customers (fleet). During the year ended December 31, 2011, it sold 71,449 new vehicles through its dealerships. During 2011, new vehicle sales were 54% of its total revenues and 22% of its total gross profit. The Company�� new vehicle revenues include new vehi! cle sale and lease transactions arranged by its dealerships with third parties.

Used Vehicle Sales

The Company sells used vehicles at all of its dealership locations. Used vehicle sales include the sale of used vehicles to individual retail customers (used retail) and the sale of used vehicles to other dealers at auction (wholesale). During 2011, it sold 55,805 used retail vehicles through its dealerships. During 2011, sales of used retail vehicles accounted for approximately 25% of its total revenues. During 2011, wholesale sales represented 4% of its total revenues.

The Company�� new vehicle operations provide its used vehicle operations with a supply of trade-ins and off-lease vehicles. It also purchases a portion of its used vehicle inventory at auctions restricted to new vehicle dealers and open auctions, which offer vehicles sold by other dealers and repossessed vehicles. Its used vehicle inventory is sold as wholesale if a vehicle is not sold at retail within 60 days, except for used vehicles, which does not fit within its inventory mix. The reconditioning of used vehicles also generates revenue for its parts and service departments.

Parts and Service

Asbury sells replacement parts and provides vehicle maintenance and collision repair service at all of its franchised dealerships, for the vehicle brands sold at those dealerships. As of December 31, 2011, in addition, it maintained 25 free-standing collision repair centers either on the premises of, or in close proximity to, its dealerships. During 2011, parts and service revenues accounted for approximately 14% of its total revenues.

Finance and Insurance

The Company refers to the finance and insurance portion of its business as F&I. Through its F&I business, it arranges, and receives commissions for, third-party financing of the sale or lease of new and used vehicles to customers, as well as offers a range of aftermarket products, such as extended servi! ce contra! cts, guaranteed asset protection (GAP) debt cancellation, pre-paid maintenance and credit life and disability insurance. It also generates F&I revenues from the receipt of marketing fees paid to it under agreements with preferred lenders. During 2011, its F&I business generated approximately 3% of its total revenues. Extended service contracts cover repair work after the expiration of the manufacturer warranty. GAP debt cancellation covers the customer after a total loss for the difference between the value of the vehicle and the outstanding loan or lease obligation after insurance proceeds. Prepaid maintenance covers routine maintenance work, such as oil changes, cleaning and adjusting of brakes, multi-point vehicle inspections and tire rotations. Credit life and disability covers the remaining amounts due on an auto loan or a lease in the event of death or disability.

The Company earns sales-based commissions from third-party lenders, including manufacturer captive finance subsidiaries which arranges on behalf of its customers. It may be charged back (chargebacks) for these commissions in the event a finance contract is cancelled or repaid, typically within the first 90 days of such contract. During 2011, it arranged customer financing on approximately 70% of the vehicles it sold. The Company is a party to a range of preferred lender agreements. These payments are determined by the lenders based upon an agreed-upon earnings schedule.

Advisors' Opinion:
  • [By Jeremy Bowman]

    What: Shares of Asbury Automotive Group (NYSE: ABG  ) were revving up today, gaining as much as 15% after posting a strong earnings report.

  • [By Inyoung Hwang]

    Fresnillo Plc (FRES) and Polymetal International Plc sank at least 7 percent to lead declines in the Stoxx 600 after the precious-metals producers were not included in the NYSE Arca Gold Miners Index. Fresnillo tumbled 13 percent to 1,045 pence. Polymetal plunged 7.1 percent to 659.5 pence. African Barrick Gold Plc (ABG) also fell, losing 12 percent to 143.9 pence.

10 Best Quality Stocks To Invest In 2014: Tauriga Sciences Inc (TAUG)

Tauriga Sciences, Inc., formerly Immunovative, Inc., incorporated on April 18, 2001, is a development-stage company. The Company along with Constellation Diagnostics, Inc. (Constellation) focuses on establishing a joint venture partnership to develop and commercialize a imaging-based diagnostic technology for use in predictive and preventative oncology.

The Company has rights to commercialize AlloStim and AlloVax. As of March 31, 2013 the Company did not have any revenues.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:

  • [By Peter Graham]

    Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:

10 Best Quality Stocks To Invest In 2014: Medidata Solutions Inc.(MDSO)

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. Its solutions comprise software and services that allow customers to increase the value of their development programs by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. The company primarily offers Medidata Rave, a comprehensive platform for capturing and managing clinical data. It also provides Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a protocol development tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a busi ness analytics platform; and Medidata Balance, a randomization and trial supply management solution, which streamlines the process of developing, building, and implementing subject allocation plans. In addition, the company offers Medidata Grants Manager, an application to benchmark the investigator budgets against industry data; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. Further, it provides hosting, support, and professional services. The company serves pharmaceutical, biotechnology, and medical device companies; academic institutions; and CROs and other entities engaged in clinical trials through a direct sales force; and through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.

Advisors' Opinion:
  • [By Kevin Marder]

    Among the names, Medidata Solutions (MDSO) is a developer of clinical development software for use in the research of new medical treatments. Most Wall Street analysts forecast earnings growth of 38% in 2013 and 13% in 2014. Revenue growth over the past several quarters has been very steady, at 21%, 24%, 26%, 27% and 27%, respectively.

  • [By Ben Levisohn]

    Einhorn mentioned operating margin estimates are too high and that similar companies to Athenahealth have margins around 10%. Our expectations aren�� that much higher, as we estimate Athenahealth will finish 2014 with adjusted operating margins of 10.3%, increasing to 11.4% and 12.0% in 2015 and 2016, respectively. While we expect some margin expansion, our absolute margin levels are in-line with other [software-as-a-service] peers 2014E operating margins including: Medidata (MDSO) at 8.9%, Salesforce.com (CRM) at 10.3%, and LinkedIn (LNKD) at 13.8%. While not expecting significant margin expansion in the near term, we expect Athenahealth�� margins to expand in the future, driven by declining marginal costs associated with adding additional providers to its user base. Additionally, as the top-line growth slows, we expect the company to cut back on its investments, allowing earnings to flow through the bottom line.

  • [By Monica Gerson]

    Medidata Solutions (NASDAQ: MDSO) shares slipped 17.91% to $43.25 after the company reported downbeat quarterly results.

    Arotech (NASDAQ: ARTX) shares declined 10.98% to $3.97 after falling 1.55% on Monday.

  • [By Brian Stoffel]

    But I'm not here to talk about these two companies
    I offer those two up as examples that this trend of profiting while helping medical companies save money, is very real. The company I'd like to introduce you to today is much smaller: Medidata Solutions (NASDAQ: MDSO  ) .

10 Best Quality Stocks To Invest In 2014: Materion Corporation (MTRN)

Materion Corporation, a materials solutions company, engages in the production and supply of high-performance engineered materials in the United States and internationally. The company offers high performance materials solutions for large area coatings, alternative energy, and thin film applications; and specialty inorganic chemicals for semiconductors, LED lighting, and energy storage applications. It also provides precision thin film coatings and optical filters for manufacturers in the defense, commercial, space, science, astronomy, and thermal imaging industries; beryllium-based metals and metal matrix composites for commercial, research, and engineering applications; and copper, copper beryllium, and spinodal alloy products for end-use products in the aerospace, automotive, computers, telecommunications, manufacturing equipment, mobile equipment, medical products, oil and gas, alternative energy, and plastic tooling markets. In addition, the company offers high perfor mance engineered ceramics; beryllium X-ray window and ultra high vacuum products; electron beam welding, vacuum furnace brazing, and waterjet cutting services, as well as engineering support services; and beryllium products, such as speaker domes and microphone transducers. Further, Materion Corporation provides precision-coated materials; thin film deposition materials, electronic packaging products, and specialty materials for the semiconductor, photonics, data storage, wireless, military, and medical markets; and precision parts cleaning, precious metals refining, and recycling services. Additionally, it engages in beryllium mining and milling business; and offers engineered beryllium materials and specialty strip metal products. The company was formerly known as Brush Engineered Materials Inc. and changed its name to Materion Corporation on March 8, 2011. Materion Corporation was founded in 1931 and is headquartered in Mayfield Heights, Ohio.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    In trading on Thursday, basic materials shares were relative leaders, up on the day by about 1.20 percent. Among the leading sector stocks, gains came from Axiall (NYSE: AXLL), Materion (NYSE: MTRN), Huntsman (NYSE: HUN) and Joy Global (NYSE: JOY).

Friday, November 21, 2014

Top Medical Stocks To Invest In Right Now

Fresenius Medical Care AG (FME) fell the most in more than four years in Frankfurt after the U.S. government proposed cutting payments to kidney dialysis center operators by 9.4 percent next year.

The shares dropped as much as 10 percent, the biggest intraday decline since October 2008. The stock was down 9.7 percent at 49.18 euros as of 9:11 a.m.

Much of the $1 billion reduction in payments is the result of a federal budget-balancing agreement. That deal targeted overspending on anemia drugs such as Amgen Inc. (AMGN)�� Epogen and Aranesp for patients in Medicare, the U.S. health plan for the elderly and disabled.

The U.S. government will consider phasing in the reduction over more than one year, the Health and Human Services Department said yesterday in a regulatory filing, citing concerns it may ��mpact beneficiary access to care.��The proposal is subject to public comment and may change before taking effect.

��his is a very dramatic cut,��Robert Sepucha, Bad Homburg, Germany-based Fresenius�� senior vice president for government affairs in the U.S., said by telephone. ��e��e concerned it would push dialysis clinics under the cost of care, which is not the right thing for Medicare to be doing.��

Top 10 Solar Stocks To Invest In 2015: Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.

GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.

Advisors' Opinion:
  • [By Roberto Pedone]

     

    Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.

     

    Monday's Volume: 674,000

    Three-Month Average Volume: 222,171

    Volume % Change: 149%

     

    Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.

     

     

    From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.

     

    Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

     

Top Medical Stocks To Invest In Right Now: Cellular Dynamics International Inc (ICEL)

Cellular Dynamics International, Inc., incorporated on November 16, 2007, develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The Company�� iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). Customers use its iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in researching cellular therapeutics. The Company�� iCell product line includes four different cell types: cardiomyocytes, neurons, hepatocytes and endothelial cells. The Company is actively developing an additional seven different cell types. iCell products are a consumable designed to be used once and then reordered.

The Company manufactures its iCell products from its iPSCs. An iPSC is a cell that has the ability both to replicate indefinitely and to be transformed into any cell type in the human body. The Company�� iCell O/S consists of six products, which include iCell Cardiomyocytes, iCell Neurons, iCell Endothelial Cells, iCell Hepatocytes and MyCell.

Advisors' Opinion:
  • [By John Udovich]

    Stem cells may not be in the news much�as the sector has moved beyond the use of embryotic�ones, but small cap stem cell stocks Cellular Dynamics International Inc (NASDAQ: ICEL), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been fairly active over the past several trading days as ICEL went public, ISCO raised additional funding and BRTX grabbed more attention:

Top Medical Stocks To Invest In Right Now: KYTHERA Biopharmaceuticals Inc (KYTH)

KYTHERA Biopharmaceuticals, Inc., incorporated in June 2004, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market. The Company�� initial focus is on the facial aesthetics market. The Company�� product candidate, ATX-101, is a injectable drug in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable double chin. Based on clinical trials conducted, ATX-101 has exhibited results in the reduction of submental fat. ATX-101 contains a synthetic form of sodium deoxycholate. In the United States and Canada, the Company is conducting two pivotal Phase III trials of ATX-101 for the reduction of submental fat. The Company initiated this pivotal Phase III clinical program, with planned enrollment of 1,000 patients, in March 2012.

In Europe, Bayer, its collaborator outside the United States and Canada, recently completed two pivotal Phase III trials of ATX-101 for the reduction of submental fat. In these multi-center, randomized, double-blind, placebo-controlled pivotal trials involving 723 patients, ATX-101 resulted in a reduction in submental fat, as assessed by a validated clinician scale and a patient satisfaction scale.

ATX-101 contains a synthetic form of sodium deoxycholate. ATX-101 is designed to be a locally-injected drug that causes proximal, preferential destruction of adipocytes, or fat cells, with minimal effect on surrounding tissue. Upon subcutaneous injection under the skin, ATX-101 disrupts cell membranes in protein-poor tissues, such as fat, while being attenuated by interactions with protein-rich tissue, such as skin, muscle and blood vessels. This attenuation by protein-rich tissue results in the preferential destruction of adipocytes by ATX-101. The destruction of adipocytes, or adipocytolysis, elicits a natural response, in which macrophages are attracted to remove cellular debris and fat particles t! hrough the lymphatic system. The macrophages also emit low levels of chemical messengers, known as cytokines, which attract fibroblasts, another cell type, to the area. Fibroblasts produce collagen, and it is believed that new collagen production, or neocollagenesis, promotes retraction of the skin in the areas of fat reduction. The fat removal process with ATX-101 is incremental with each treatment, thereby allowing for control of the aesthetic outcome.

Advisors' Opinion:
  • [By Lisa Levin]

    Kythera Biopharmaceuticals (NASDAQ: KYTH) shares surged 24.40% to touch a new 52-week high of $41.71 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

  • [By Roberto Pedone]

    Kythera Biopharmaceuticals (KYTH) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. This stock closed up 12.2% to $31.99 in Monday's trading session.

    Monday's Volume: 221,000

    Three-Month Average Volume: 72,572

    Volume % Change: 220%

    From a technical perspective, KYTH ripped sharply higher here right above its 50-day moving average of $26.92 with heavy upside volume. This move pushed shares of KYTH into new all-time-high territory above its previous all-time high at $31.93, which is bullish technical price action.

    Traders should now look for long-biased trades in KYTH as long as it's trending above Monday's low of $28.28 and then once it sustains a move or close above its new all-time high at $32 with volume that hits near or above 72,572 shares. If we get that move soon, then KYTH will set up to enter new all-time-high territory, which is bullish price action. Some possible upside targets off that move are $35 to $37.

Top Medical Stocks To Invest In Right Now: Cytomedix Inc (CMXI)

Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.

The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.

The AutoloGel System

The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.

Angel Product Line

The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.

ALDHbr Cell Technology and Development Pipeline

The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.

The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.

The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.

Advisors' Opinion:
  • [By Bryan Murphy]

    When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.

  • [By James E. Brumley]

    To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.

Top Medical Stocks To Invest In Right Now: ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173, 00 square feet, the Company manufactures oral solid dose products, as well as liquids and topicals, including narcotics. Its other products include The Food and Drug Administration (FDA) approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. In December 2013, the Company acquired 31 generic drug products from Teva Pharmaceuticals, which includes 20 solid-oral immediate release products, four extended release products and seven liquid products.

The Company performs contract manufacturing for other pharmaceutical companies. It has launched three products and has 11 products in development. The Company�� targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities.

Advisors' Opinion:
  • [By Monica Gerson]

    ANI Pharmaceuticals (NASDAQ: ANIP) reported that it has bought 31 generic drug products from Teva Pharmaceuticals (NYSE: TEVA) for $12.5 million in cash and a percentage of future gross profits. ANI Pharmaceuticals shares surged 5.14% to $18.00 in the after-hours trading session.

  • [By Ben Levisohn]

    ANI Pharmaceuticals (ANIP) has climbed 8.9% to $18.80 after it said it would buy 31 generic drugs from Teva Pharmaceuticals (TEVA). Teva’s shares are little changed in pre-open trading.

Top Medical Stocks To Invest In Right Now: Cell Therapeutics Inc (CTIC)

Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib.

Pixuvri

As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.

OPAXIO

OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.

Tosedostat

In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML.

Brostallicin

As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).

The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.

Advisors' Opinion:
  • [By John Udovich]

    Large and small cap cancer stocks Gilead Sciences, Inc (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Veracyte (NASDAQ: VCYT), Genomic Health, Inc (NASDAQ: GHDX), Cell Therapeutics Inc (NASDAQ: CTIC) and MetaStat Inc (OTCMKTS: MTST) have all been producing a steady stream of news lately for biotech investors looking for a way to cash in on the growth in development of�cancer treatments. Just consider the following news:

  • [By John Udovich]

    If you have not been watching the biotech sector lately, you should start paying attention as the sector along with small cap biotech stocks like Cell Therapeutics Inc (NASDAQ: CTIC), BIND Therapeutics Inc (NASDAQ: BIND) and TNI BioTech (OTCMKTS: TNIB) continue to produce a steady stream of good news for investors thanks to positive industry trends. Moreover, Ophthotech Corp (NASDAQ: OPHT), Foundation Medicine Inc (NASDAQ: FMI), Evoke Pharma and Fate Therapeutics Inc (NASDAQ: FATE) are this week's biotech IPOs that will no doubt be watched closely by Wall Street and industry observers in general. With that in mind, consider the following biotech news or recent articles about the industry and the small cap players in it:

Thursday, November 20, 2014

5 Best Financial Stocks For 2014

Let me tell you about a guy I know named Nat.

Nat's known for enjoying the finer things in life. His 40th birthday was held at a marina in billionaire hotspot Montenegro. Palm trees were flown in from Uruguay. Caterers were brought in specially from London. Billionaires from across the globe were in attendance.

How did Nat join the billionaire elite?

On the surface, he appears to have built his more than $1.5 billion personal fortune in the metals and mining industries.

But look a little deeper and you'll see that Nat's biggest advantage has been his family's reputation and financial backing.

 

That's because Nat is short for Nathaniel. His full name is Nathaniel Philip Victor James Rothschild. He's the latest descendant of the legendary Rothschild family... one of the world's most powerful dynasties since the late 18th century.

Top 10 Safest Stocks To Buy Right Now: WisdomTree International Dividend Ex Financial Fund (DOO)

WisdomTree International Dividend Top 100 Fund (The Fund) is a non-diversified fund. It seeks investment results that closely correspond to the price and yield performance, before fees and expenses, of the WisdomTree International Dividend Top 100 Index (The Index). The fund is managed by WisdomTree Asset Management, Inc.

The Index measures the performance of the 100 highest dividend-yielding companies in the WisdomTree International LargeCap Dividend Index. The Index is created by selecting the top 100 companies ranked by highest dividend yield from the WisdomTree International LargeCap Dividend Index.

Advisors' Opinion:
  • [By Eric Lam]

    ��ompanies that come to market are coming from sectors that work,��said Brian Huen, managing partner at Red Sky Capital Management Ltd. in Toronto. He helps manage C$220 million with the firm, and participated in the offerings for Choice Properties, Information Services Corp., and Ski-Doo maker BRP Inc. (DOO) ��eople certainly aren�� bringing any gold IPOs to market. So investors are focusing on buying deals in the right markets, as opposed to the wider market which has exposure to resources.��

5 Best Financial Stocks For 2014: Bank of South Carolina Corp.(BKSC)

Bank of South Carolina Corporation operates as the holding company for The Bank of South Carolina that provides commercial banking products and services to individuals, and small and medium-sized businesses in South Carolina. The company accepts a range of deposit products, which include checking accounts, negotiable order of withdrawal accounts, savings accounts, individual retirement accounts, and other time deposits, such as daily money market accounts and longer-term certificates of deposit. It also offers various commercial loans, including secured and unsecured loans for working capital, business expansion, and purchasing machinery and equipment; mortgage loans; industrial loans; real estate loans; loans to individuals for household, family, and other personal expenditures; and other loans, including overdrafts. In addition, the company provides Internet banking services, including online bill pay and remote deposit capture; credit cards; check card services; and saf e deposit boxes, letters of credit, travelers checks, direct deposit of payroll, social security and dividend payments, and automatic payment of insurance premiums and mortgage loans. Further, it offers a courier service and ACH origination service as part of its deposit services for commercial customers; and a portfolio of wealth management/trust, investment, and retirement services. The company has four banking house locations in Charleston, Summerville, and Mt. Pleasant, South Carolina. It serves customers in Berkeley, Charleston, and Dorchester counties. The company was founded in 1986 and is headquartered in Charleston, South Carolina.

Advisors' Opinion:
  • [By Marc Bastow]

    Financial institutions holding company Bank of South Carolina (BKSC) raised its dividend 8.3% to 13 cents per share, payable on Oct. 31 to shareholders of record as of Oct. 7.
    BKSC Dividend Yield: 3.72%

5 Best Financial Stocks For 2014: CSB Bancorp Inc (CSBB)

CSB Bancorp, Inc. (CSB), incorporated in 1991, is a financial holding company. The Commercial and Savings Bank of Millersburg, Ohio (the Bank) is a wholly owned subsidiary of the Company. CSB operates primarily through the Bank and its other subsidiaries, providing a range of banking, trust, financial and brokerage services to corporate, institutional and individual customers throughout northeast Ohio. The Bank provides retail and commercial banking services to its customers, including checking and savings accounts, time deposits, individual retirement accounts (IRAs), safe deposit facilities, personal loans, commercial loans, real estate mortgage loans, installment loans, night depository facilities, brokerage and trust services.

Lending Activities

The Bank provides residential real estate, commercial real estate, commercial and consumer loans to customers located primarily in Holmes, Tuscarawas, Wayne, Stark and portions of surrounding counties in Ohio. Commercial loan rates are variable as well as fixed, and include operating lines of credit and term loans made to small businesses, primarily based on their ability to repay the loan from the cash flow of the business. Business assets, such as equipment, accounts receivable and inventory typically secure such loans. Commercial real estate loans are primarily secured by borrower-occupied business real estate. Commercial real estate loans are generally originated with a loan-to-value ratio of 80% or less. Commercial construction loans are secured by commercial real estate and in most cases the Bank also provides the permanent financing. Residential real estate loans carry both fixed and variable rates and are secured by the borrower�� residence. Home equity lines of credit are made to individuals and are secured by second or first mortgages on the borrower�� residence. Installment loans to individuals include loans secured by automobiles and other consumer assets, including second mortgages on personal residences.

Investment Activities

As of December 31, 2011, the Company�� securities available-for-sale totaled $123,026,000. Its portfolio of securities available-for-sale includes the United States treasury securities, the United States Government corporations and agencies, mortgage-backed securities, obligations of states and political subdivisions, equity securities, and corporate bonds.

Sources of Funds

As of December 31, 2011, the Company�� portfolio of deposits included noninterest-bearing demand, interest-bearing demand deposits, savings deposits and time deposits. Short-term borrowings consist of securities sold under agreements to repurchase, short-term advances through Federal Home Loan Bank and federal funds purchased.

Advisors' Opinion:
  • [By CRWE]

    Today, CSBB remains (0.00%) +0.000 at $18.75 thus far (ref. google finance Delayed: 3:53PM EDT July 30, 2013).

    CSB Bancorp, Inc. previously reported second quarter 2013 net income of $1.25 million or $.45 per basic and diluted share, as compared to $1.14 million or $.41 per basic and diluted share for the same period in 2012.

    Annualized returns on average common equity (��OE�� and average assets (��OA�� for the quarter were 9.32% and 0.88%, respectively, compared with 8.98% and 0.82% for the second quarter of 2012.

    Eddie Steiner, President and CEO commented, ��e continue to focus on growing relationships with current and new customers. The bank�� average loan balances have increased 10% in the past year, and although margins remain tight, this growth has provided increases of approximately 4% in net interest income.��/p>

5 Best Financial Stocks For 2014: Citigroup Inc.(C)

Citigroup, Inc., a global financial services company, provides consumers, corporations, governments, and institutions with a range of financial products and services. The company operates through two segments, Citicorp and Citi Holdings. The Citicorp segment operates as a global bank for businesses and consumers with two primary businesses, Regional Consumer Banking and Institutional Clients Group. The Regional Consumer Banking business provides traditional banking services, including retail banking, and branded cards in North America, Asia, Latin America, Europe, the Middle East, and Africa. The Institutional Clients Group business provides securities and banking services comprising investment banking and advisory services, lending, debt and equity sales and trading, institutional brokerage, foreign exchange, structured products, cash instruments and related derivatives, and private banking; and transaction services consisting of treasury and trade solutions, and securiti es and fund services. The Citi Holdings segment operates Brokerage and Asset Management, Local Consumer Lending, and Special Asset Pool businesses. The Brokerage and Asset Management Business, through its 49% stake in Morgan Stanley Smith Barney joint venture and Nikko Cordial Securities, offers retail brokerage and asset management services. The Local Consumer Lending business provides residential mortgage loans, retail partner card loans, personal loans, commercial real estate, and other consumer loans, as well as western European cards and retail banking services. The Special Asset Pool business is a portfolio of securities, loans, and other assets. Citigroup Inc. has approximately 200 million customer accounts and operates in approximately 160 countries. The company was founded in 1812 and is based in New York, New York.

Advisors' Opinion:
  • [By Matt Koppenheffer]

    Bank of America� (NYSE: BAC  ) ,�JPMorgan Chase� (NYSE: JPM  ) ,�Citigroup� (NYSE: C  ) ,�Wells Fargo� (NYSE: WFC  ) ,�Morgan Stanley� (NYSE: MS  ) , and�Goldman Sachs� (NYSE: GS  ) are the primary targets of the bill, as it would require a draconian capital buffer on any bank with assets above $500 billion. It would also do away with the use of risk-weighted assets, which allows banks to carry less capital for assets deemed less risky. It's essentially a big, blunt club that batters the biggest banks with a 15% capital requirement.

  • [By John Grgurich]

    Up, up, and away
    But before we dive into that, here's a quick overview of where B of A and its peers are at the start of the trading day:

    B of A is up 1.16%. Citigroup (NYSE: C  ) is up 0.77%. JPMorgan Chase (NYSE: JPM  ) is up 0.62%. And Wells Fargo (NYSE: WFC  ) -- never quite as volatile either up or down as its big-four peers--is up 0.54%.

    Foolish bottom line
    If you go to your favorite finance website, pull up each of the big four banks, and look at their performance on a graph over the last five business days, you'll see pretty much the same thing: big drops on Wednesday and Thursday, followed by slow climbs out of the basement on Friday and Monday, and sizable gains yesterday.

  • [By Telis Demos]

    Alan Rifkin, who joins from Citigroup(C), will run the Americas unit of its Strategic Equity Solutions Group from New York starting in May, according to an internal memo.

  • [By Jessica Alling]

    Citigroup (NYSE: C  ) gets 18% to 20% of its revenue from the Asian markets, and has fallen almost 2.9% in the first two hours of trading. Citi has already demonstrated in its first-quarter earnings report that its Asian markets had softened, so further deterioration of revenue streams from the region could hurt the bank's chances of offsetting those declines in other markets.

10 Best Media Stocks To Buy For 2014

The sweet spot for investors right now seems to be companies with strong brands, rising dividends, and fairly reliable earnings streams. Disney (DIS) shares seem to fall perfectly into that sweet spot.

The stock has held up well during the market�� recent bout of volatility, and I expect these shares to outpace the overall market for 2013 and over the long term.

The company�� diverse operating base, from broadcasting to theme parks to movies, should generate steady profit gains, and record per-share earnings are expected for fiscal 2013 ending in September.

Disney is a major player in media, with its ESPN unit perhaps the most prized asset on the cable dial. The company also owns ABC network. An improving economy should fuel increased advertising revenue for the broadcasting business.

Top Asian Stocks To Own For 2015: DIRECTV(DTV)

DIRECTV provides digital television entertainment in the United States and Latin America. The company provides direct-to-home (DTH) digital television services, as well as multi-channel video programming distribution services in the United States. It offers various channels of digital-quality video entertainment and CD-quality audio programming directly to subscribers' homes or businesses, as well as video-on-demand services; and approximately 160 national high-definition television channels and 4 3D channels. The company also provides premium professional and collegiate sports programming, such as the NFL SUNDAY TICKET package, which allows subscribers to view the NFL games. In addition, it offers DTH digital television services in Latin America and the Caribbean, including Puerto Rico. The company provides its local and international programming under the DIRECTV and SKY brand names. As of December 31, 2010, it served approximately 19.2 million subscribers in the United States; and 8.9 million subscribers in Latin America. The company was founded in 1990 and is based in El Segundo, California.

Advisors' Opinion:
  • [By Jon C. Ogg]

    We still have many key oil and energy companies reporting in the week ahead but we have now seen the sector leaders report earnings. Earnings previews have been prepared for the following stocks:

    CME Group Inc. (NASDAQ: CME) Hertz Global Holdings Inc. (NYSE: HTZ) Kellogg Company (NYSE: K) DirecTV (NASDAQ: DTV) Office Depot Inc. (NYSE: ODP) and OfficeMax Incorporated (NYSE: OMX) Tesla Motors Inc. (NASDAQ: TSLA) T-Mobile US, Inc. (NYSE: TMUS) American Water Works Company Inc. (NYSE: AWK) Duke Energy Corp. (NYSE: DUK) QUALCOMM Inc. (NASDAQ: QCOM) Time Warner Inc. (NYSE: TWX) Whole Foods Market Inc. (NASDAQ: WFM) Groupon Inc. (NASDAQ: GRPN) Molycorp Inc. (NYSE: MCP) The Walt Disney Company (NYSE: DIS) Priceline.com Inc. (NASDAQ: PCLN) The Wendy’s Company (NYSE: WEN)

    CME Group Inc. (NASDAQ: CME) reports earnings on Monday morning. With all of the exchange mergers of the last decade this remains one of the dominant exchanges. Estimates are $0.73 EPS and $713.3 million in revenue. Keep in mind that this exchange is now worth $25 billion. At $74.70, the consensus analyst price target is only just barely higher at almost $75.50.

10 Best Media Stocks To Buy For 2014: Liberty Global Inc.(LBTYA)

Liberty Global, Inc. provides video, broadband Internet, and telephony services primarily in Europe and Chile. The company offers broadband services over cable distribution systems, including video, broadband Internet, and telephony; and video services through direct-to-home satellite, or through multichannel multipoint distribution systems. Its analog video services comprise basic and expanded basic programming; and digital cable services include basic and premium programming, digital video recorders, and high definition programming, as well as pay-per-view programming, such as video-on-demand and near video-on-demand. In addition, the company offers voice-over-Internet-protocol and circuit-switched telephony services, as well as mobile telephony services using third-party networks. Further, it owns programming networks that provide video programming channels to multi-channel distribution systems owned by the company and the third parties. As of December 31, 2011, the com pany owned and operated networks that passed 33,262,100 homes; and served 18,405,500 video subscribers, 8,159,300 broadband Internet subscribers, and 6,225,300 telephony subscribers. Liberty Global, Inc. was founded in 2004 and is based in Englewood, Colorado.

Advisors' Opinion:
  • [By Amy Thomson]

    Vodafone has already expanded beyond wireless service, and in June beat John Malone�� Liberty Global (LBTYA) Plc to take over Germany�� Kabel Deutschland Holding AG. (KD8) Vodafone and Verizon accelerated talks on the stake sale after the Kabel Deutschland offer, which put additional pressure on the British company�� finances, a person familiar with the matter said.

  • [By GuruFocus]

    Warren Buffett (Trades, Portfolio) added to his holdings in Wal-Mart Stores Inc by 17.32%. His purchase prices were between $72.66 and $78.91, with an estimated average price of $75.43. The impact to his portfolio due to this purchase was 0.62%. His holdings were 58,052,412 shares as of 03/31/2014.

    Added: Liberty Global PLC (LBTYA)

    Warren Buffett (Trades, Portfolio) added to his holdings in Liberty Global PLC by 149.19%. His purchase prices were between $40.36 and $45.96, with an estimated average price of $43.34. The impact to his portfolio due to this purchase was 0.17%. His holdings were 7,346,968 shares as of 03/31/2014.

10 Best Media Stocks To Buy For 2014: Gannett Co. Inc. (GCI)

Gannett Co., Inc. operates as a media and marketing solutions company in the United States and internationally. Its Publishing segment publishes 83 U.S. daily newspapers with affiliated online sites, including USA TODAY, a national, general-interest daily newspaper; USATODAY.com; USA WEEKEND, a magazine supplement for newspapers; Clipper Magazine, a direct mail advertising magazine; bi-weekly Nursing Spectrum and NurseWeek periodicals; and military and defense newspapers. This segment also includes 17 paid-for daily newspapers; approximately 200 weekly newspapers, magazines, and trade publications; and approximately 600 non-daily publications, as well as involves in commercial printing, newswire, marketing, and data services operations. The company?s Digital segment owns and operates CareerBuilder, an employment Web site, which offers online recruitment and career advancement services for employers, employees, recruiters, and job seekers; ShopLocal, which provides multicha nnel shopping and advertising services; Planet Discover, which offers hosted search and advertising services; PointRoll, which provides digital marketing services and technology; and Schedule Star, which offers scheduling solution for high school athletic departments. Its Broadcasting segment operates 23 television stations and affiliated Web sites, which produce local programming, such as news, sports, and entertainment programming. This segment also includes Captivate Network, a national news and entertainment network that delivers programming and full-motion video advertising on video screens located in elevators of office towers and select hotel lobbies in North America. The company has strategic business relationships with online affiliates, including Classified Ventures, ShopLocal.com, Topix, and Metromix LLC, as well as strategic marketing agreement with Microsoft. Gannett Co., Inc. was founded in 1906 and is headquartered in McLean, Virginia.

Advisors' Opinion:
  • [By Mike Deane]

    Early on Monday morning, Gannett (GCI) had its price target raised to $35 from $34 at FBR Capital. The ratings company also affirmed that Gannett is a “Top Pick.”�

    Gannett, a publishing and broadcasting company that operates in the U.S. and the U.K., currently has a price of $29.76, and FBR’s new target suggests an 18% upside.

    FBR analyst William Bird had the following comments about GCI’s PT raise: “Based on our analysis, we estimate that Gannett’s spectrum is worth approximately $2.2 billion, or $9 per share, roughly doubling in value from the�acquisition�of BLC (i.e., pre-deal valuation of ~$1.1 billion). Separately, we are lowering our 2014 EPS estimate by $0.07 to reflect the previously announced sale of three stations to MDP (note: an expected midyear close means that the stations will not be in operating results from January 1, but the proceeds will not be received until midyear). We are increasing our price target to $35 from $34 to reflect shareholder accretion from the sale. We like Gannett’s improving business mix, growth profile, and ability to drive growth with its own propeller through higher retrans, synergies, and potential TV acquisitions.”

    Gannett stock was inactive in pre-market trading. So far this year, the company’s stock is up 0.61%.

  • [By Douglas A. McIntyre]

    Traditional media sites did unusually well, given that they are not the core products of their parent companies. Broadcaster CBS (NYSE: CBS) was in 9th place at 80.9 million unique visitors in November. Comcast NBCUniversal was 14th place with 64.4 million. Gannett (NASDAQ: GCI) sites were 16th at 57 million. Viacom had 54.3 million, and ESPN 38.7 million.

  • [By Monica Gerson]

    Gannett Co (NYSE: GCI) is expected to report its Q3 earnings at $0.41 per share on revenue of $1.27 billion.

    VMware (NYSE: VMW) is projected to report its Q3 earnings at $0.82 per share on revenue of $1.29 billion.

  • [By Sue Chang and Saumya Vaishampayan]

    Gannett Co. (GCI) �shares shed 2.8%. USA Today on Monday said it reached a content and technology partnership with CineSport that will provide a video-technology platform as well as create video content.

10 Best Media Stocks To Buy For 2014: Discovery Communications Inc(DISCA)

Discovery Communications, Inc. operates as a non fiction media and entertainment company worldwide. The company provides original and purchased programming across various distribution platforms. Its content covers science, exploration, survival, natural history, sustainability of the environment, technology, docu-series, anthropology, paleontology, history, space, archaeology, health and wellness, engineering, adventure, lifestyles, forensics, civilization, and current events. The company owns and operates nine national television networks in the United States, including Discovery Channel, TLC, Animal Planet, Science Channel, Investigation Discovery, Military Channel, Planet Green, Discovery Fit & Health, and Velocity. Discovery Communications also has interests in Oprah Winfrey Network, a pay-television network and Web site; The Hub that features original programming, game shows, and live-action series and specials; and 3net, a three-dimensional network. In addition, it o ffers network branded Web sites, and mobile and video-on-demand services; and distributes various national and pan-regional television networks. Further, the company develops and sells curriculum-based products and services to public and private K-12 schools, such as access to an online VOD service that includes curriculum-based tools, professional development services, and student assessment and publication of hardcopy curriculum-based content; and postproduction audio services to motion picture studios, independent producers, broadcast networks, cable channels, advertising agencies, and interactive producers. As of December 31, 2011, it operated approximately 150 distribution feeds in 40 languages. The company is headquartered in Silver Spring, Maryland.

Advisors' Opinion:
  • [By Alyce Lomax]

    An hour is the amount of time Americans might allot for watching an episode of, say, Dirty Jobs in their free time. Speaking of jobs, dirty or otherwise, Discovery Communications' (NASDAQ: DISCA  ) CEO David Zaslav's pay calculation came to $24,000 per hour.

  • [By Ben Levisohn]

    So yes, Disney is a Buy, and DiClemente’s $90 price target suggests another 19% of upside from yesterday’s close, though it should be noted he also likes CBS (CBS), Twenty-First Century Fox (FOXA) and Discover Communications (DISCA).

  • [By Lauren Pollock]

    Discovery Communications Inc.(DISCA) is mulling a bid for Scripps Network Interactive Inc.(SNI), the owner of cable channels like the Food Network and HGTV, according to a person familiar with the matter. Shares of Scripps jumped 10% to $83.01 premarket.

  • [By Julianne Pepitone]

    At $45 a share, Wieser pointed out, Twitter's valuation isn't too far below more established media companies like CBS (CBS, Fortune 500), Discovery Communications (DISCA) and Yahoo (YHOO, Fortune 500).

10 Best Media Stocks To Buy For 2014: Time Warner Inc.(TWX)

Time Warner Inc. operates as a media and entertainment company in the United States and internationally. It operates in three segments: Networks, Filmed Entertainment, and Publishing. The Networks segment provides domestic and international networks, premium pay and basic tier television programming services, and digital media properties, which primarily consist of brand-aligned Websites. Its premium pay television services consist of the multi-channel HBO and Cinemax premium pay television services. This segment provides programming to cable system operators, satellite service distributors, telephone companies, and other distributors; sells advertising; and licenses original programming to domestic and international television networks. The Filmed Entertainment segment produces and distributes feature films, television and other programming, and videogames; distributes home video products; and licenses rights to its feature films, television programming, and characters. T he Publishing segment publishes magazines and books; and operates various Websites, as well as engages in marketing services and direct-marketing businesses. This segment publishes magazines on style and entertainment, lifestyle, news, and sports. The company?s brands include TNT, TBS, CNN, HBO, Cinemax, Warner Bros., New Line Cinema, People, Sports Illustrated, and Time. Time Warner Inc. was founded in 1985 and is headquartered in New York, New York.

Advisors' Opinion:
  • [By Tim Beyers]

    According to reports, Despicable Me 2 edged Grown Ups 2 $44.8 million to $42.5 million in U.S ticket sales. Pacific Rim, a big bet for both Time Warner (NYSE: TWX  ) and co-financier Legendary Pictures, finished third with $38.3 million at the box office.

    Color me surprised by the outcome, even if history says I shouldn't be. Box Office Mojo data shows "animation' as the fourth most common film genre, with 317 films accounting for some $18.2 billion in gross domestic receipts. DreamWorks Animation's (NASDAQ: DWA  ) 2004 blockbuster, Shrek 2, tops the list at $441.2 million.

10 Best Media Stocks To Buy For 2014: Time Warner Cable Inc(TWC)

Time Warner Cable Inc., together with its subsidiaries, operates as a cable operator in the United States. It offers video, high-speed data, and voice services over its broadband cable systems to residential and commercial customers. The company provides a range of video services, including on-demand, high-definition (HD), and digital video recorder (DVR) services; residential high-speed data services with connection to the Internet; wireless mobile broadband Internet services; and digital phone services to residential customers. It offers video programming tiers and music services; high-speed data, networking, and transport services; and commercial digital phone service to small and medium-sized businesses under the Time Warner Cable Business Class brand. Further, Time Warner Cable Inc. sells advertising to various national, regional, and local customers. As of June 30, 2011, the company served approximately 14.5 million residential and commercial customers in the New Yor k State, the Carolinas, Ohio, southern California, and Texas. Time Warner Cable Inc. is based in New York, New York.

Advisors' Opinion:
  • [By Rich Smith]

    Time Warner Cable (NYSE: TWC  ) has a new chief financial officer -- acquired from its old sister company, AOL (NYSE: AOL  ) .

  • [By Jayson Derrick]

    This morning, Time Warner Cable (NYSE: TWC) reported its second quarter results. The company announced an EPS of $1.89, beating the consensus estimate of $1.91. Revenue of $5.73 billion missed the consensus estimate of $5.75 billion. Net income for the quarter rose to $499 million from $481 million in the same quarter a year ago, as the company saw its average revenue per user grow by 1.7 percent to $106.98 and the company saw a record second-quarter subscriber volume growth. The company noted that it saw 42,000 residential triple play net additions, 67,000 residential high-speed data net additions, 79,000 residential net additions and business primary service unit and customer relationship net additions of 37,000 and 21,000, respectively. Shares lost 4.17 percent, closing at $145.10.

  • [By Rick Aristotle Munarriz]

    CBS"NCIS" is CBS' top rated drama. From left: Mark Harmon, guest star Colin Hanks, and Pauley Perrette. The market was loving CBS (CBS) on Tuesday, but don't be surprised if the love affair doesn't last. Shares of the broadcasting giant soared nearly 5 percent after it resolved a month-long dispute with Time Warner Cable (TWC) that had kept its channels off the air for the cable provider's 11.7 million customers. But there will be a price to pay for being unavailable to so many cable subscribers for so much of this summer, and we're not just talking about the immediate hit in the current quarter. Customers are getting tired of the games that content providers pay, and CBS is feeding the resentment as it tries to get subscribers to pay more for CBS, The CW, and lesser watched channels including Smithsonian Channel and TVGN. We don't know the terms of new carriage deal, but we know who's actually going to be paying the price: The average Time Warner Cable video customer's bill is up 8.5 percent over the past year. Is it any wonder why the pay TV industry is starting to lose customers? Audiences Are Thinning Out Industry analysts at UBS predict that cable and satellite television providers will lose 250,000 net subscribers this year. It will be the first year that the pay TV industry suffers an annual decline. CBS can argue that it's better off than its sibling Viacom (VIA), which takes in a more significant level of its television revenue from cable subscription fees. CBS has its namesake broadcast channel and more than two dozen local stations. A lot of people cutting the cord to save money will simply invest in HD antennas that they can use to access over-the-air channels including CBS. Well, it's not that easy. Local broadcast advertising was actually one of the few CBS businesses to see its profits decline in its latest quarter. The company blamed the decline on the loss of election-year political ad spending, but could it be that folks just aren't as p

  • [By WALLSTCHEATSHEET]

    Time Warner Cable provides entertainment, voice, and high-speed data services to a growing customer base in the United States. The company lost 215,000 video subscribers in the fourth quarter. The stock has been pulling back in recent times and is currently trading sideways. Over the last four quarters, earnings have been mixed while revenues have been rising which has produced conflicting feelings among investors. Relative to its peers and sector, Time Warner Cable has been an average year-to-date performer. WAIT AND SEE what Time Warner Cable does this quarter.

10 Best Media Stocks To Buy For 2014: Cablevision Systems Corporation (CVC)

Cablevision Systems Corporation provides telecommunications and media services. It operates in two segments, Telecommunications Services and Other. The Telecommunications Services segment is involved in television business, including video, high-speed data, and VoIP operations, as well as the provision of commercial data and voice services. The Other segment offers Newsday, a daily newspaper; amNewYork, a free daily newspaper; and Star Community Publishing, a group of weekly shopper publications; and newsday.com and exploreLI.com. This segment also engages in motion picture theatre business, Clearview Cinemas; provision of the News 12 Networks, a regional news programming services; and the MSG Varsity network, a network covering high school sports and activities, and other local programs, as well as cable television advertising. Cablevision Systems Corporation was founded in 1985 and is headquartered in Bethpage, New York.

Advisors' Opinion:
  • [By Rich Duprey]

    Both Bow Tie and Cablevision (NYSE: CVC  ) , which owned the Clearview chain, announced yesterday they had completed the transfer of ownership of the theaters, which was first announced in April, though financial terms for the transaction were not disclosed. As the oldest cinema company in the U.S.,�Bow Tie says it now has the largest number of theater locations in the New York metropolitan area,�and operates 63 movie theaters with 388 screens in seven states.

  • [By Anna Prior]

    Cablevision Systems Corp.(CVC) said it swung to a profit in the first quarter, driven by higher rates and advertising sales that boosted its cable revenue.

  • [By Sean Williams]

    For a second day in a row, we need to look no further than the broadcasting sector for our best performers. Time Warner Cable (NYSE: TWC  ) and Cablevision (NYSE: CVC  ) advanced 8.1% and 3.5%, respectively, on speculation that a wave of mergers and acquisitions would sweep through the sector. If you recall, Gannett�shares soared after announcing a $1.5 billion purchase of Belo�yesterday to expand its national broadcasting presence.